CLINICAL EVALUATION OF 5-(3,3-DIMETHYL-1-TRIAZENO)IMIDAZOLE-4-CARBOXAMIDE IN MALIGNANT MELANOMA AND OTHER NEOPLASMS - COMPARISON OF TWICE-WEEKLY AND DAILY ADMINISTRATION SCHEDULES

被引：26

作者：

GOTTLIEB, JA

SERPICK, AA

机构：

来源：

关键词：

D O I：

10.1159/000224572

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：225 / &

共 9 条

[1]

LUCE JK, 1970, P AM ASSOC CANC RES, V11, P50

[2]

LUCE JK, 1970, CANCER CHEMOTH REP 1, V54, P119

[3]

MACDONALD C, 1967, P AM ASSOC CANC RES, V8, P43

[4]

MOON JH, 1970, CANCER, V26, P468, DOI 10.1002/1097-0142(197008)26:2<468::AID-CNCR2820260231>3.0.CO

[5]

2-2

[6]

NATHANSON L, 1970, CLIN RES, V18, P474

[7] ANTITUMOR ACTIVITY OF TRIAZENOIMIDAZOLES [J].

SHEALY, YF ;

LASTER, WR ;

MONTGOMERY, JA .

[8]

SKIBBA JL, 1969, CANCER RES, V29, P1944

[9]

1968, CLINICAL BROCHURE 5